Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 774
Average round size
The average size of a deal this fund participated in
Portfolio companies 410
Rounds per year 14.60
Lead investments 118
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 251
Key employees 14
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Software
  • Medical
  • Information Technology

In 1969 was created Venrock, which is appeared as VC. The main department of described VC is located in the Palo Alto. The company was established in North America in United States.

The fund is constantly included in 25-48 deals per year. The important activity for fund was in 2007. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from Venrock is 100-500 millions dollars. Opposing the other organizations, this Venrock works on 2 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 8 percentage points more often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Venrock, startups are often financed by Third Rock Ventures, OrbiMed, Lux Capital. The meaningful sponsors for the fund in investment in the same round are Trellis Partners, Sequoia Capital, Investor Growth Capital Limited. In the next rounds fund is usually obtained by MPM Capital, Investor Growth Capital Limited, Sequoia Capital.

The overall number of key employees were 14.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Juno Therapeutics, AveXis, Receptos. Among the most popular fund investment industries, there are Health Care, Information Technology.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Venrock:
Typical Co-investors
Venrock is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Venrock:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Mythic Therapeutics

Health Care
$103M15 Dec 2021 Massachusetts, United States


Artificial Intelligence
Health Care
Machine Learning
Natural Language Processing
$55M07 Dec 2021 Redwood City, California, United States


Air Transportation
$200M27 Oct 2021 California, United States

Stride Health

Employee Benefits
Financial Services
Financial Software
Health Care
Health Insurance
Life and Health Insurance
$47M26 Oct 2021 San Francisco, California, United States

Rebellion Defense

Artificial Intelligence
Machine Learning
$150M16 Sep 2021 Washington, District of Columbia, United States


$11M30 Aug 2021 Los Angeles, California, United States


Artificial Intelligence
Machine Learning
Risk Management
Supply Chain Management
$100M22 Jul 2021 Arlington, Virginia, United States

Atom Computing

Information Technology
Product Research
$15M21 Jul 2021 Berkeley, California, United States

Element Biosciences

Information Technology
$276M29 Jun 2021 San Diego, California, United States
Interos Raises $100M in Series C Financing

– Interos is an Arlington, VA-based supply chain risk management and operational resilience technology company.
– The company raised $100m in Series C funding.
– The round was led by NightDragon with participation from current investors Kleiner Perkins and Venrock.
– The new investment will be used to expand operations and business reach.

Element Biosciences Raises $276M in Series C Financing

– Element Biosciences from San Diego develops DNA sequencing platform.
– The company closed a $276m Series C financing.
– Backers included new investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price and existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock.
– The new investment will be used to scale commercial organization in anticipation of the launch of its next-generation sequencing solution.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Venrock?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: